{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:47:37Z","timestamp":1774532857578,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Toxicologic Pathology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.etp.2009.09.001","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T08:55:41Z","timestamp":1253782541000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats"],"prefix":"10.1016","volume":"63","author":[{"given":"Geraldo","family":"de Oliveira Silva-Junior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago","family":"da Silva Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"de Souza Mendonca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Alberto Mandarim-de-Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.etp.2009.09.001_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0026-0495(99)90021-5","article-title":"Troglitazone and vascular reactivity: role of glucose and calcium","volume":"48","author":"Ali","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.etp.2009.09.001_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/01.HYP.0000196728.05488.c3","article-title":"Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo","volume":"47","author":"Benkirane","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.etp.2009.09.001_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3132\/dvdr.2007.029","article-title":"Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat","volume":"4","author":"Bolten","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.etp.2009.09.001_bib4","doi-asserted-by":"crossref","first-page":"H30","DOI":"10.1152\/ajpheart.2001.281.1.H30","article-title":"Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR","volume":"281","author":"El Mabrouk","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.etp.2009.09.001_bib5","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diabetes.53.2007.S43","article-title":"The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity","volume":"53","author":"Ferre","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.etp.2009.09.001_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/10520295609113767","article-title":"A selective stain for elastic tissue (orcinol-new fuchsin)","volume":"31","author":"Fullmer","year":"1956","journal-title":"Stain Technol"},{"key":"10.1016\/j.etp.2009.09.001_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcp.2006.09.019","article-title":"Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells \u2013 role of PPAR-gamma in vascular fibrosis","volume":"73","author":"Gao","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.etp.2009.09.001_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00395-006-0613-4","article-title":"Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide","volume":"102","author":"Gonon","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.etp.2009.09.001_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0163-7827(01)00005-4","article-title":"The roles of PPARs in adipocyte differentiation","volume":"40","author":"Grimaldi","year":"2001","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.etp.2009.09.001_bib10","doi-asserted-by":"crossref","first-page":"849538","DOI":"10.1155\/2009\/849538","article-title":"PPARgamma2 polymorphism and human health","volume":"2009","author":"He","year":"2009","journal-title":"PPAR Res"},{"key":"10.1016\/j.etp.2009.09.001_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa073394","article-title":"Rosiglitazone evaluated for cardiovascular outcomes \u2013 an interim analysis","volume":"357","author":"Home","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.etp.2009.09.001_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.HYP.0000036396.64769.C2","article-title":"Antiinflammatory and antiarteriosclerotic effects of pioglitazone","volume":"40","author":"Ishibashi","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.etp.2009.09.001_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/01.HYP.37.2.371","article-title":"Antisense inhibition of brain renin\u2013angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats","volume":"37","author":"Kagiyama","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.etp.2009.09.001_bib14","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0140-6736(07)60824-1","article-title":"Cardiovascular safety of rosiglitazone","volume":"369","author":"Krall","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.etp.2009.09.001_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.phrs.2006.03.020","article-title":"Antihypertensive effect of ragaglitazar: a novel PPARalpha and gamma dual activator","volume":"54","author":"Mamnoor","year":"2006","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.etp.2009.09.001_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0001-37652003000400006","article-title":"Stereological tools in biomedical research","volume":"75","author":"Mandarim-de-Lacerda","year":"2003","journal-title":"An Acad Bras Cienc"},{"key":"10.1016\/j.etp.2009.09.001_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000146448","article-title":"Quantitative study of the heart in 2 human twin embryos at 14mm C-R (stage 18)","volume":"130","author":"Mandarim-de-Lacerda","year":"1987","journal-title":"Acta Anat (Basel)"},{"key":"10.1016\/j.etp.2009.09.001_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(96)10508-0","article-title":"Impaired synthesis of elastin in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension","volume":"350","author":"Martyn","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.etp.2009.09.001_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2613.2007.00546.x","article-title":"Cardiac and aortic structural alterations due to surgically-induced menopause associated with renovascular hypertension in rats","volume":"88","author":"Mendonca","year":"2007","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.etp.2009.09.001_bib20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1440-1681.2003.03906.x","article-title":"Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats","volume":"30","author":"Mill","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.etp.2009.09.001_bib21","first-page":"H687","article-title":"Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42\/44 MAPK","volume":"291","author":"Molavi","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.etp.2009.09.001_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10557-005-5059-7","article-title":"Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats","volume":"18","author":"Nagai","year":"2004","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.etp.2009.09.001_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.diabres.2005.02.012","article-title":"Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients","volume":"70","author":"Negro","year":"2005","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.etp.2009.09.001_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0021-9150(90)90027-G","article-title":"Age-related changes in the elastic tissue of the human thoracic aorta","volume":"80","author":"Nejjar","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.etp.2009.09.001_bib25","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.etp.2009.09.001_bib26","first-page":"559","article-title":"Morphometry of medial hypertrophy in the rat thoracic aorta","volume":"42","author":"Olivetti","year":"1980","journal-title":"Lab Invest"},{"key":"10.1016\/j.etp.2009.09.001_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.prp.2003.12.008","article-title":"Aortic wall remodeling in rats with nitric oxide deficiency treated by enalapril or verapamil","volume":"200","author":"Pereira","year":"2004","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.etp.2009.09.001_bib28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00004872-200409000-00022","article-title":"Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase","volume":"22","author":"Sarafidis","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.etp.2009.09.001_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.metabol.2004.07.008","article-title":"Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial","volume":"54","author":"Smith","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.etp.2009.09.001_bib30","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.CIR.102.15.1834","article-title":"Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells","volume":"102","author":"Takeda","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.etp.2009.09.001_bib31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1291\/hypres.31.965","article-title":"Effects of rosiglitazone (a peroxysome proliferator-activated receptor gamma agonist) on the blood pressure and aortic structure in metabolically programmed (perinatal low protein) rats","volume":"31","author":"Torres","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.etp.2009.09.001_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20080195","article-title":"PPARgamma and its ligands: therapeutic implications in cardiovascular disease","volume":"116","author":"Villacorta","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.etp.2009.09.001_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.amjhyper.2004.04.010","article-title":"Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats","volume":"17","author":"Wu","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.etp.2009.09.001_bib34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/diabetes.54.2.554","article-title":"Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia\/reperfusion-induced myocardial injury","volume":"54","author":"Yue","year":"2005","journal-title":"Diabetes"}],"container-title":["Experimental and Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299309002401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299309002401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:58:43Z","timestamp":1760547523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0940299309002401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":34,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0940299309002401"],"URL":"https:\/\/doi.org\/10.1016\/j.etp.2009.09.001","relation":{},"ISSN":["0940-2993"],"issn-type":[{"value":"0940-2993","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats","name":"articletitle","label":"Article Title"},{"value":"Experimental and Toxicologic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etp.2009.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}